PRME vs AKUS
Comparison between Prime Medicine Inc (PRME, Company) and Akouos Inc (AKUS, Company).
PRME vs AKUS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
PRME
$489M
Winner
AKUS
$490M
Max Drawdown
PRME
94.55%
Winner
AKUS
90.86%
Sharpe Ratio
Winner
PRME
1.05
AKUS
0.86
5Y Beta
PRME
2.13
AKUS
N/A
Industry
PRME
Biotechnology
AKUS
N/A
P/E Ratio
PRME
-2.26
Winner
AKUS
-5.30
Debt to Equity
PRME
0.00%
AKUS
0.00%
Free Cash Flow Yield
PRME
-32.43%
Winner
AKUS
-15.58%
P/S Ratio
PRME
121.34
AKUS
N/A
P/B Ratio
PRME
6.38
Winner
AKUS
2.71
PRME vs AKUS - Historical Returns
Returns include dividend reinvestment.
1M
PRME
-15.91%
Winner
AKUS
+0.00%
3M
PRME
-25.60%
Winner
AKUS
+95.44%
6M
PRME
-32.32%
Winner
AKUS
+327.33%
1Y
Winner
PRME
+90.07%
AKUS
+46.37%
Max(CAGR)
PRME
-37.48%
Winner
AKUS
-18.12%
PRME vs AKUS - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | PRME | AKUS |
|---|---|---|
| 2026 | -21.39% | N/A |
| 2025 | +16.05% | N/A |
| 2024 | -66.67% | N/A |
| 2023 | -49.49% | +0.00% |
| 2022 | +20.88% | +46.37% |
| 2021 | N/A | -56.25% |
| 2020 | N/A | -9.86% |
PRME vs AKUS Drawdown Comparison
The maximum drawdown for PRME was -94.55%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The maximum drawdown for AKUS was -90.86%, occurring on May 25, 2022. This drawdown has not yet recovered.
The current PRME drawdown is -86.86%. The current AKUS drawdown is -50.63%.
| Rank | PRME | AKUS |
|---|---|---|
| #1 | -94.55% Nov 1, 2022 - Apr 8, 2025 | -90.86% Sep 14, 2020 - May 25, 2022 |
| #2 | -3.55% Oct 21, 2022 - Oct 25, 2022 | -14.22% Jun 30, 2020 - Aug 28, 2020 |
| #3 | N/A | -7.97% Sep 2, 2020 - Sep 8, 2020 |
| #4 | N/A | -4.37% Sep 9, 2020 - Sep 14, 2020 |
| #5 | N/A | -0.80% Aug 28, 2020 - Sep 1, 2020 |
Correlation
Correlation between PRME and AKUS is -0.66 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.
-0.66
-101
Select Stocks to Compare
Popular: PRME vs SPYAKUS vs SPY
More Comparisons
Compare with similar stocks